Loading video...

Video Failed to Load

Go Home

𝐀𝐈 𝐍𝐞𝐰𝐬: Bay Area based Medra, which is building a robotics platform that is capable of doing fully automated lab work for drug discovery and then analyzing and optimizing it, announced a $52M series A today. Full video:

BiotechTV's profile picture

BiotechTV

10,745 subscribers

15,086 views • 8 months ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:
5:19

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:

BiotechTV

22,484 views • 1 year ago

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Marea Therapeutics today announced acceptance of a late-breaker at #EASCongress2025 for its ANGPTL4 inhibitor - believed to be the first ever clinical data presented for this lipid lowering target. Full video:
6:12

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Marea Therapeutics today announced acceptance of a late-breaker at #EASCongress2025 for its ANGPTL4 inhibitor - believed to be the first ever clinical data presented for this lipid lowering target. Full video:

BiotechTV

14,073 views • 1 year ago

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:
3:36

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,894 views • 1 year ago

𝐀𝐈 𝐍𝐞𝐰𝐬: Why does healthcare productivity barely move, even as technology improves? A new JAMA commentary from former FDA commissioner Scott Gottlieb, MD 🇺🇸 argues that AI could finally change that if regulation and reimbursement catch up. Article link:
2:45

𝐀𝐈 𝐍𝐞𝐰𝐬: Why does healthcare productivity barely move, even as technology improves? A new JAMA commentary from former FDA commissioner Scott Gottlieb, MD 🇺🇸 argues that AI could finally change that if regulation and reimbursement catch up. Article link:

BiotechTV

13,800 views • 8 months ago

🚨IT IS A MATCH🚨 Just in, the glove that detectives found and sent to a lab IS A MATCH for the glove that the kidnapper was wearing in the video. THIS IS A HUGE DISCOVERY!
0:33

🚨IT IS A MATCH🚨 Just in, the glove that detectives found and sent to a lab IS A MATCH for the glove that the kidnapper was wearing in the video. THIS IS A HUGE DISCOVERY!

Ashley (TeamTrump47)

307,254 views • 5 months ago

𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐌&𝐀 𝐍𝐞𝐰𝐬: Lilly is acquiring Crossbridgebio, a Texas biotech developing dual payload antibody-drug conjugates, for up to $300M. Co-Founder & CEO Michael Torres tells us.
4:50

𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐌&𝐀 𝐍𝐞𝐰𝐬: Lilly is acquiring Crossbridgebio, a Texas biotech developing dual payload antibody-drug conjugates, for up to $300M. Co-Founder & CEO Michael Torres tells us.

BiotechTV

20,285 views • 3 months ago

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:
3:01

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 views • 1 month ago

Presentation of the MenteeBot V3 humanoid robots by the Israeli company Mentee Robotics: a fully autonomous team-based workflow. The MenteeBot V3 operates completely autonomously and is already capable of performing logistics and assembly-line tasks in factories. The robot is 175 centimeters tall and equipped with two NVIDIA Jetson Orin AGX processors, which provide full autonomous functionality.
1:14

Presentation of the MenteeBot V3 humanoid robots by the Israeli company Mentee Robotics: a fully autonomous team-based workflow. The MenteeBot V3 operates completely autonomously and is already capable of performing logistics and assembly-line tasks in factories. The robot is 175 centimeters tall and equipped with two NVIDIA Jetson Orin AGX processors, which provide full autonomous functionality.

NEXTA

34,084 views • 8 months ago

Demis Hassabis just described the exact architecture he is building to cure all human disease and said the breakthrough will not come gradually. It will hit all at once. He is building a full platform to do it. Think of it as a dozen AlphaFold-level models, each one covering a different step in the drug discovery process, all stitched together into a single engine that can be pointed at almost any disease area on earth. AlphaFold solved protein structure. It then folded 200 million proteins in a single year. Hassabis is now building the equivalent of that for every other step like protein interactions, molecular binding, toxicity prediction, drug design, and clinical stratification. Each one its own AlphaFold. All of them connected. He is already testing it on disease profiles in pre-clinical stages right now. Most biotech analysts still model drug discovery timelines in decades. McKinsey published a report estimating AI could reduce discovery timelines by 25 to 50 percent. Hassabis is not describing a 25 percent improvement. He is describing a complete replacement of the process. Do not expect a slow drip of results. Expect nothing for a few years and then a sudden explosion where everything works at once. Demis is running the same play. At a scale that makes AlphaFold look like a warm-up act. (Watch the full interview on YouTube at Two Minute Papers channel)
2:29

Demis Hassabis just described the exact architecture he is building to cure all human disease and said the breakthrough will not come gradually. It will hit all at once. He is building a full platform to do it. Think of it as a dozen AlphaFold-level models, each one covering a different step in the drug discovery process, all stitched together into a single engine that can be pointed at almost any disease area on earth. AlphaFold solved protein structure. It then folded 200 million proteins in a single year. Hassabis is now building the equivalent of that for every other step like protein interactions, molecular binding, toxicity prediction, drug design, and clinical stratification. Each one its own AlphaFold. All of them connected. He is already testing it on disease profiles in pre-clinical stages right now. Most biotech analysts still model drug discovery timelines in decades. McKinsey published a report estimating AI could reduce discovery timelines by 25 to 50 percent. Hassabis is not describing a 25 percent improvement. He is describing a complete replacement of the process. Do not expect a slow drip of results. Expect nothing for a few years and then a sudden explosion where everything works at once. Demis is running the same play. At a scale that makes AlphaFold look like a warm-up act. (Watch the full interview on YouTube at Two Minute Papers channel)

Ihtesham Ali

101,258 views • 1 month ago

"A lab leak could be that someone was out in the wild, maybe looking for different types of viruses in bats, got infected, went into a lab, and was being studied in a lab, and then it came out of the lab. But if that's the definition of a lab leak, Jim, then that still is a natural occurrence."
0:20

"A lab leak could be that someone was out in the wild, maybe looking for different types of viruses in bats, got infected, went into a lab, and was being studied in a lab, and then it came out of the lab. But if that's the definition of a lab leak, Jim, then that still is a natural occurrence."

Nicholson Baker

1,842,718 views • 3 years ago

$RKLB Rocket Lab Robotics is very exciting! It makes Rocket Lab "one of the few companies in the world capable of delivering Mars missions across the entire spectrum. That's launch, spacecraft, software, and now Mars proven robotics for surface and on orbit operations." More info in the video below 👇
3:07

$RKLB Rocket Lab Robotics is very exciting! It makes Rocket Lab "one of the few companies in the world capable of delivering Mars missions across the entire spectrum. That's launch, spacecraft, software, and now Mars proven robotics for surface and on orbit operations." More info in the video below 👇

ValueOverPrice

13,475 views • 1 month ago

Most people in the Bay Area are familiar with Georgia Tech as the HPC Garage parallel computing research lab. Not a lot of Bay Area techies know that the state is also home to the University of Georgia which apparently is good at football.
0:42

Most people in the Bay Area are familiar with Georgia Tech as the HPC Garage parallel computing research lab. Not a lot of Bay Area techies know that the state is also home to the University of Georgia which apparently is good at football.

SemiAnalysis

28,282 views • 9 months ago

Residents of Pangani have raised concerns over a cracked building in the area that poses a significant danger to both its occupants and neighbors. The building is fully occupied.
0:23

Residents of Pangani have raised concerns over a cracked building in the area that poses a significant danger to both its occupants and neighbors. The building is fully occupied.

The Kenyan Vigilante

77,522 views • 4 months ago

Tesla is a robotics company. It is a machine that builds machines. All of the work they’re doing on cars translates to the Optimus robot. And if there’s a shortlist of companies that will benefit from an intelligence explosion from AI? Tesla is on that list.
1:44

Tesla is a robotics company. It is a machine that builds machines. All of the work they’re doing on cars translates to the Optimus robot. And if there’s a shortlist of companies that will benefit from an intelligence explosion from AI? Tesla is on that list.

Mckay Wrigley

84,249 views • 1 year ago

🇻🇪🇷🇺 "Russia is a great world power, but it is capable of building relations based on the principles of equality, respect, and cooperation" — Venezuelan President Nicolas Maduro Adds that Venezuela-Russia relations are exemplary
5:21

🇻🇪🇷🇺 "Russia is a great world power, but it is capable of building relations based on the principles of equality, respect, and cooperation" — Venezuelan President Nicolas Maduro Adds that Venezuela-Russia relations are exemplary

Lord Bebo

14,299 views • 9 months ago

We at ACT Labs are building the future of robotics engineering in a way that anyone can contribute and earn The cursor for robotics is here A major change is coming for Roba Labs 😏
9:48

We at ACT Labs are building the future of robotics engineering in a way that anyone can contribute and earn The cursor for robotics is here A major change is coming for Roba Labs 😏

imdecentralized (defi/ai)

22,682 views • 8 months ago

just a reminder, my usage of the word “based” is an act of reclamation from altright losers and ugly nazis who stole it. as a born resident of the bay area, i will always honor and protect the true meaning of based
0:31

just a reminder, my usage of the word “based” is an act of reclamation from altright losers and ugly nazis who stole it. as a born resident of the bay area, i will always honor and protect the true meaning of based

harm reduction hedonista🃏

288,773 views • 8 months ago